ADAR1 Capital Management’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $525K | Sell |
176,627
-166,885
| -49% | -$496K | 0.08% | 109 |
|
|
2025
Q1 | $783K | Sell |
343,512
-430,123
| -56% | -$981K | 0.15% | 84 |
|
|
2024
Q4 | $2.89M | Sell |
773,635
-185,936
| -19% | -$695K | 0.58% | 36 |
|
|
2024
Q3 | $2.88M | Hold |
959,571
| – | – | 0.47% | 38 |
|
|
2024
Q2 | $2.8M | Buy |
959,571
+742,190
| +341% | +$2.17M | 0.53% | 28 |
|
|
2024
Q1 | $745K | Buy |
217,381
+182,849
| +530% | +$626K | 0.17% | 65 |
|
|
2023
Q4 | $99.8K | Buy |
+34,532
| New | +$99.8K | 0.04% | 84 |
|